Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v10-FR Version v8-FR
Language French French
Date Updated 2021-01-07 2020-11-12
Drug Identification Number 02316080 02316080
Brand name ACT QUETIAPINE ACT QUETIAPINE
Common or Proper name QUETIAPINE 25MG FC TAB QUETIAPINE 25MG FC TAB
Company Name TEVA CANADA LIMITED TEVA CANADA LIMITED
Ingredients QUETIAPINE QUETIAPINE
Strength(s) 25MG 25MG
Dosage form(s) TABLET TABLET
Route of administration ORAL ORAL ORAL ORAL
Packaging size 500 500
ATC code N05AH N05AH
ATC description ANTIPSYCHOTICS ANTIPSYCHOTICS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2020-08-05 2020-08-05
Estimated end date 2020-12-31 2020-12-31
Actual end date 2021-01-06
Shortage status Resolved Actual shortage
Company comments
Health Canada comments